ArticleIJID regions2026
Host and pathogen factors modulate tuberculosis clinical severity independent of molecular bacterial burden: insights from a multicenter Ghanaian cohort.
Article in IJID regions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Tuberculosis (TB) exhibits marked clinical heterogeneity, complicating prognosis, and disease management. Identifying reliable predictors of disease trajectory and severity could improve risk stratification. Methodology: We investigated determinants of TB severity in 727 sputum-positive individuals recruited from five health facilities in Ghana. Participants were classified as TB-only, TB-human immunodeficiency virus, or TB-diabetes mellitus. Disease severity was assessed using the Bandim TB score II. Bacterial burden was quantified using GeneXpert Results: Bacterial load differed modestly across comorbidity groups, but GeneXpert cycle threshold values showed no significant correlation with clinical severity (Spearman's ρ = -0.006, Conclusion: Host nutritional status, socio-demographic factors, and pathogen genotype were more consistently associated with TB severity than molecular bacterial burden alone, supporting a host-pathogen interaction framework to explain clinical heterogeneity and improve management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.